"There are many ways to define excellence. For The Christ Hospital in Cincinnati, OH, it's all about our patients. And making healthcare what they want it to be. Accessible. Personal. Affordable."

During the past decade, University of Cincinnati Physicians Company conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 21 clinical trials were completed, i.e. on average, 123.5% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 8 clinical trials were completed. i.e. 114.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Cincinnati Physicians Company" #1 sponsor was "Shire" with 3 trials, followed by "TherapeuticsMD" with 3 trials sponsored, "Conatus Pharmaceuticals Inc." with 2 trials sponsored, "GlycoMimetics Incorporated" with 2 trials sponsored and "Ipsen" with 2 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Cincinnati Physicians Company" #1 collaborator was "Clinical Research Management, Inc." with 1 trials as a collaborator, "Foundation Medicine" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Myriad Genetics, Inc." with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "University of Cincinnati Physicians Company" are "Cervical Dystonia" (2 trials), "Hepatic Cirrhosis" (2 trials), "Hereditary Angioedema" (2 trials), "Liver Cirrhosis" (2 trials) and "Menopause" (2 trials). Many other conditions were trialed in "University of Cincinnati Physicians Company" in a lesser frequency.

Most popular intervention types in "University of Cincinnati Physicians Company" are "Drug" (27 trials), "Biological" (4 trials), "Other" (4 trials), "Device" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Botulinum toxin type A" (2 trials), "Estradiol" (2 trials), "IDN-6556" (2 trials) and "Participating Site's standard practice" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Cincinnati Physicians Company" are 28 trials for "All" genders and 9 trials for "Female" genders.

Currently, there are NaN active trials in "University of Cincinnati Physicians Company". undefined are not yet recruiting, 6 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in University of Cincinnati Physicians Company, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in University of Cincinnati Physicians Company, 4 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".